Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Culture Company (C3) is a specialized contract development and manufacturing organization (CDMO) focused on the production of proteins and antibodies for the diagnostic and therapeutic industries. The company utilizes proprietary Acusyst hollow fiber perfusion bioreactor technology, which allows for high-density cell growth and continuous production over extended periods. C3 provides services ranging from cell line adaptation and process development to large-scale GMP manufacturing. Their expertise spans monoclonal antibodies, recombinant proteins, and emerging modalities like cell-based therapies and exosomes. Headquartered in Minneapolis, the company serves a global client base including virtual biotechs and large pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Cultures.